Literature DB >> 21831624

Lipid and smoker's inclusions in sputum macrophages in patients with airway diseases.

Andrew M Wilson1, Parameswaran Nair, Frederick E Hargreave, Ann E Efthimiadis, Mehran Anvari, Christopher J Allen.   

Abstract

We studied the effect of tobacco smoking on macrophage lipid index and macrophage smokers inclusions in induced sputum in 256 patients (143 non-smokers, 81 ex-smokers and 32 current smokers). Lipid index was, using the Oil red O stain, the sum of the lipid staining droplet score (range 0-4) in 100 macrophages. Smokers inclusions were assessed using Wright's stain and graded as "none", "few", "moderate" or "many". Lipid index was significantly higher in current smokers (112.5, SD 58.5 units) than ex-smokers (29.2, SD 42.8 units) or non-smokers (13.4, SD 121.7). Smokers inclusions were present in all current smokers but only in 2 non-smokers. The mean smoking history of current smokers with few macrophage inclusions was 15.0 (SD 11.2), moderate 21.6 (SD 15.7), and many 30.0 (SD 21.9) pack years. There was a significant difference between the length of time ex-smokers had quit smoking if they had no or few smokers inclusions (mean 17.6 (SD 11.2) years) compared to those with moderate or many smokers inclusions (mean 2.8 (SD 5.8) years) (p = 0.01). Lipid index was significantly correlated with smokers inclusions (r = 0.72, p < 0.01). We conclude that smoker's inclusions within sputum macrophages is a reliable indicator of cigarette smoking and that the sputum lipid index cannot be used as an assessment of oropharyngeal reflux in cigarette smokers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21831624     DOI: 10.1016/j.rmed.2011.07.011

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  7 in total

Review 1.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

2.  Lipid laden macrophages and electronic cigarettes in healthy adults.

Authors:  Peter G Shields; Min-Ae Song; Jo L Freudenheim; Theodore M Brasky; Joseph P McElroy; Sarah A Reisinger; Daniel Y Weng; Rongqin Ren; Thomas Eissenberg; Mark D Wewers; Konstantin Shilo
Journal:  EBioMedicine       Date:  2020-09-10       Impact factor: 8.143

3.  Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study.

Authors:  Sindu Mohan; Terence Ho; Melanie Kjarsgaard; Katherine Radford; A S M Borhan; Lehana Thabane; Parameswaran Nair
Journal:  BMC Pulm Med       Date:  2017-04-12       Impact factor: 3.317

Review 4.  Lipid Metabolism Disorders in the Comorbid Course of Nonalcoholic Fatty Liver Disease and Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov; Aleksei Bulgakov
Journal:  Cells       Date:  2021-11-01       Impact factor: 6.600

5.  Smoking status impacts treatment efficacy in smoke-induced lung inflammation: A pre-clinical study.

Authors:  Nadia Milad; Marie Pineault; Félix Tremblay; Joanie Routhier; Ariane Lechasseur; Marie-Josée Beaulieu; Sophie Aubin; Mathieu C Morissette
Journal:  Front Pharmacol       Date:  2022-09-07       Impact factor: 5.988

Review 6.  Participation of ABCA1 Transporter in Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Stanislav Kotlyarov
Journal:  Int J Mol Sci       Date:  2021-03-24       Impact factor: 5.923

7.  Increased Monocyte-Derived CD11b+ Macrophage Subpopulations Following Cigarette Smoke Exposure Are Associated With Impaired Bleomycin-Induced Tissue Remodelling.

Authors:  Steven P Cass; Olivia Mekhael; Danya Thayaparan; Joshua J C McGrath; Spencer D Revill; Matthew F Fantauzzi; Peiyao Wang; Amir Reihani; Aaron I Hayat; Christopher S Stevenson; Anna Dvorkin-Gheva; Fernando M Botelho; Martin R Stämpfli; Kjetil Ask
Journal:  Front Immunol       Date:  2021-09-16       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.